PTC Therapeutics nabs 'phase 3 ready' biotech Censa for just $10M upfront plus stock 0 07.05.2020 14:05 Fiercebiotech.com PTC Therapeutics is adding to its rare disease pipeline with a midstage biotech buyout with a low upfront payment tied in with stock and biobucks. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
